Correction to: Intravenous Ferric Carboxymaltose in Patients with Type 2 Diabetes Mellitus and Iron Deficiency: CLEVER Trial Study Design and Protocol
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.